Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Optimizing Carbon Ratios in Concrete Enhances Carbon Accounting Accuracy

June 4, 2026
Continue Reading
optimizing-carbon-ratios-in-concrete-enhances-carbon-accounting-accuracy
Posted inBiotechnology

HuR Drives RyR2 Expression for Brown Fat Thermogenesis

June 4, 2026
Continue Reading
hur-drives-ryr2-expression-for-brown-fat-thermogenesis
Posted inBiotechnology

Urine Dipstick vs Consensus Standard in Elderly UTI Diagnosis

June 4, 2026
Continue Reading
urine-dipstick-vs-consensus-standard-in-elderly-uti-diagnosis
Posted inBiotechnology

Commensal Acetylcholine Boosts Mucosal Immunity

June 4, 2026
Continue Reading
commensal-acetylcholine-boosts-mucosal-immunity
Posted inBiotechnology

Next-Gen 3D Models Revolutionize Lymphoid Cancer Research

June 4, 2026
Continue Reading
next-gen-3d-models-revolutionize-lymphoid-cancer-research
Posted inBiotechnology

Peptide GV1001 Reverses Alzheimer’s Neurodegeneration in Mice

June 4, 2026
Continue Reading
peptide-gv1001-reverses-alzheimer’s-neurodegeneration-in-mice
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

aadi-pulls-commercial-to-preclinical-pivot,-buying-adcs-and-selling-approved-drug-to-reboot-business
Posted inBiotechnology

Aadi pulls commercial-to-preclinical pivot, buying ADCs and selling approved drug to reboot business

December 20, 2024
Aadi Bioscience has rebooted its operations, transforming from a commercial business into a preclinical biotech by offloading its approved product and…
Read More
mechanism-for-cellular-rna’s-role-in-antiviral-immune-response-uncovered
Posted inGenetics

Mechanism for Cellular RNA’s Role in Antiviral Immune Response Uncovered

December 20, 2024
New research from scientists at the University of Washington (UW) School of Medicine and Duke University describes how cellular RNA…
Read More
ai-expedites-motor-neuron-analysis-and-screening-in-als-research
Posted inGenetics

AI Expedites Motor Neuron Analysis and Screening in ALS Research

December 20, 2024
Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding…
Read More
fda-rejects-zealand-pharma’s-glp-2-analog-in-rare-bowel-disease
Posted inBiotechnology

FDA rejects Zealand Pharma’s GLP-2 analog in rare bowel disease

December 19, 2024
The FDA has denied Zealand Pharma’s approval bid for glepaglutide—a possible challenger to Takeda’s Gattex—in short bowel syndrome (SBS), citing…
Read More
flu-vaccine-response-boosted-by-coupling-antigens-from-multiple-subtypes
Posted inGenetics

Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes

December 19, 2024
The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount…
Read More
pyxis-oncology-shelves-antibody-to-focus-on-sole-clinical-asset,-an-adc-licensed-from-pfizer
Posted inBiotechnology

Pyxis Oncology shelves antibody to focus on sole clinical asset, an ADC licensed from Pfizer

December 19, 2024
Pyxis Oncology is shelving a clinical-stage monoclonal antibody to focus on its lead antibody-drug conjugate (ADC) after sharing preliminary results…
Read More
oncology-biotech-epitopea-licenses-genevant-nucleic-acid-delivery-tech-for-up-to-$123m
Posted inBiotechnology

Oncology biotech Epitopea licenses Genevant nucleic acid delivery tech for up to $123M

December 19, 2024
To develop RNA medicines targeting a proprietary bundle of tumor antigens, Epitopea is tapping nucleic acid delivery specialist Genevant Sciences…
Read More
chutes-&-ladders—fda’s-principal-deputy-to-depart-agency
Posted inBiotechnology

Chutes & Ladders—FDA’s principal deputy to depart agency

December 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Read More
omeros-antibody-improves-overall-survival-by-68%-in-rare-condition,-new-analysis-finds
Posted inBiotechnology

Omeros antibody improves overall survival by 68% in rare condition, new analysis finds

December 19, 2024
Omeros is putting up its monoclonal antibody up for FDA approval—again. This time, the resubmission will be based on a…
Read More
merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More

Posts pagination

Previous page 1 … 1,902 1,903 1,904 1,905 1,906 … 1,917 Next page
You May Have Missed
imu-biosciences-nabs-$53m-funding-round-to-‘decode’-the-immune-system
Posted inMedical Technology

IMU Biosciences nabs $53M funding round to ‘decode’ the immune system

foundation-medicine-tallies-fda-nod-to-pair-its-blood-test-with-pfizer’s-prostate-cancer-combo
Posted inMedical Technology

Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo

mindmaze-therapeutics-culls-program,-ends-legacy-ops-from-relief-merger-to-cut-costs
Posted inMedical Technology

MindMaze Therapeutics culls program, ends legacy ops from Relief merger to cut costs

human-longevity-launches-newco,-teams-with-insilico-for-ai-powered-longevity-research
Posted inMedical Technology

Human Longevity launches newco, teams with Insilico for AI-powered longevity research

Privacy Policy    Terms

Scroll to Top